New wave · Worldwide
New precision medicine startups, founded 2020 on
The new wave: 62 precision medicine startups founded in 2020 or later that have raised money in rounds we track, $1.8B between them, placed in 3 segments.
62startups on the map
3segments
$1.8Braised between them
Precision oncologymost funded segment
Treeline Biosciences
Scorpion Therapeutics
MOMA Therapeutics
Abdera Therapeutics
Flare Therapeutics
Synnovation Therapeutics
Stipple Bio
Nested Therapeutics
Haystack Oncology
Solu Therapeutics
Alphina Therapeutics
Elephas
CoSyne Therapeutics
Predicta Biosciences
Imagene AI
Valar Labs
Macomics
Hedera Dx
Incyclix Bio
OneCell Diagnostics
StratifAI
Trial Library
Launchpad Therapeutics
ENSEM Therapeutics
+10 more
Funding by segment
- Precision oncology$1.5B34
- Companion diagnostics and biomarkers$233M23
- Data and AI platforms$127M5
Where they are based
- United States34$1.5B
- United Kingdom5$61M
- France5$18M
- Canada3$148M
- Netherlands3$11M
- Switzerland2$21M
- India1$16M
- Germany1$15M
- Australia1$1.6M
- Denmark1$548K
United States
United Kingdom
France
Canada
Netherlands
Switzerland
India
Germany
Australia
DenmarkFounded
Earlier
12
13
14
15
16
17
18
19
1820
1721
1622
723
124
325
26
Total raised
- Under $1M6
- $1M to $10M26
- $10M to $50M19
- $50M to $250M11
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
62 of 62 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States34
- United Kingdom5
- France5
- Canada3
- Netherlands3
- Switzerland2
- India1
- Germany1
- Australia1
- Denmark1
- Spain1
- South Korea1
Spain
South KoreaStartups by country, 15 countries in all.
Segment by segment
Precision oncology
34 startups · $1.5B raised
- Treeline BiosciencesTreeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.United States$200M
- Scorpion TherapeuticsScorpion Therapeutics is a clinical-stage biotechnology company specializing in precision oncology.United States$150M
- MOMA TherapeuticsMOMA Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2020.United States$150M
- Abdera TherapeuticsAbdera Therapeutics is a precision oncology company based in South San Francisco, California, with an additional office in Vancouver, Canada.Canada$142M
- Flare TherapeuticsFlare Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, founded in 2021.United States$123M
- Synnovation TherapeuticsSynnovation Therapeutics is a clinical-stage biotechnology company based in Wilmington, Delaware, founded in 2021.United States$102M
- Stipple BioStipple Bio is a biotechnology company based in Cambridge, Massachusetts, founded in 2022.United States$100M
- Nested TherapeuticsNested Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.United States$90M
Companion diagnostics and biomarkers
23 startups · $233M raised
Exai BioExai Bio is a biotechnology company based in Palo Alto, California, founded in 2021.United States$68M
Spear BioSpear Bio is a biotechnology startup based in Woburn, Massachusetts, founded in 2021.United States$45M
SapientBiomarker discovery organization accelerating drug development through rapid, large-scale small molecule biomarker profiling.United States$35M
SuperpowerSuperpower is a health-tech subscription company based in Los Angeles, founded in 2023 by Jacob Peters, Max Marchione, and Kevin Unkrich.United States$30M
thymiaThymia is a London-based health technology startup founded in 2020, recognized as the world’s first foundational voice biomarker platform.United Kingdom$8.4M
Resolve StrokeResolve Stroke is a neurotechnology company that utilizes AI to enhance transcranial ultrasound signals, enabling real-time biomarFrance$5.2M
Axo LongevityAxo Longevity is a high-performance longevity platform based in Europe, founded in 2025.United Kingdom$5.0M
ViewsMLViewsML is a Vancouver-based artificial intelligence company focused on precision medicine and diagnostics through its innovative Canada$4.9M
Data and AI platforms
5 startups · $127M raised
Zephyr AIZephyr AI is a precision medicine and healthcare technology company focused on enhancing drug discovery and clinical trials througUnited States$111M
AitiologicAitiologic is an Austrian precision medicine startup based in Vienna, founded in June 2023.Austria$7.4M
PGxAIPGxAI is an AI-powered pharmacogenetics platform that redefines precision medicine using proprietary algorithms and real-world data.United States$4.5M
Index HealthIndex Health is a Miami-based precision medicine and telehealth company founded in 2021.United States$3.0M
OASYS NOWOASYS NOW is a healthtech company based in Delft, Netherlands, founded in 2018.Netherlands$1.0M
AustriaHow this map is made. Every startup here has raised money in rounds we track, and was founded in 2020 or later. It joins the map when its sectors, read from its rounds, or the opening of its own description say it works in precision medicine, and goes to the first segment whose words it carries. Each segment shows its best-funded first. Rebuilt nightly; updated 15 November 2026.
More market maps
All mapsMarket mapPrecision medicine market map215 startups · 3 segments · $10BInvestors mapWho invests in precision medicine88 investors · 5 segmentsRaised in 2026Precision medicine startups that raised in 202637 startups · 3 segments · $2.9BMarket map · United StatesPrecision medicine market map: United States123 startups · 3 segments · $8.3BMarket map · EuropePrecision medicine market map: Europe68 startups · 3 segments · $885MMarket map · United KingdomPrecision medicine market map: United Kingdom22 startups · 3 segments · $404M
Who backs precision medicine?
Open any company for its rounds and investors, or search the investors behind these startups in the app, with filters, lists and exports.